Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients - Italian initiative on uremic hyperhomocysteinemia (IIUH)

被引:0
作者
Perna, AF
Ingrosso, D
Molino, D
Galletti, P
Montini, G
Zacchello, G
Bellantuono, R
Caringella, A
Fede, C
Chimenz, R
De Santo, NG
机构
[1] Univ Naples 2, Div Nephrol, Sch Med & Surg, Dept Pediat, I-80131 Naples, Italy
[2] Univ Naples 2, Dept Biochem & Biophys, Sch Med & Surg, I-80131 Naples, Italy
[3] Univ Padua, Div Pediat Nephrol, I-35100 Padua, Italy
[4] Pediat Hosp Giovanni XXIII, Div Pediat Nephrol, Bari, Italy
[5] Univ Messina, Div Pediat Nephrol, I-98100 Messina, Italy
[6] Reg Children Hosp, Palermo, Italy
关键词
homocysteine; protein damage; children; pediatric; chronic renal failure; uremia; kidney transplantation;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Plasma homocysteine, a new cardiovascular risk factor in both children and adults, is higher in chronic renal failure or kidney transplant patients. This alteration has been linked, in chronic renal failure, to plasma protein damage, represented by increased I-isoaspartyl residues. We measured plasma homocysteine levels and plasma protein damage in pediatric patients from four different Italian regions with conservatively treated renal failure; hemodialysis, continuous ambulatory peritoneal dialysis (CAPD), or transplants, to establish the presence of protein damage and the relative role of hyperhomocysteinemia. Methods: High performance liquid chromatography (HPLC) separation measured total plasma homocysteine levels, using precolumn derivatization with ammonium 7-fluorobenzo-2-oxa-1, 3-diazole4-sulphonate (SBD-F). Plasma protein L-isoaspartyl residues were quantitated using human recombinant protein carboxyl methyl transferase (PCMT). Results. In all patient groups, homocysteine levels were significantly higher with respect to the control (Control: 6.87 +/- 0.73 muM) conservatively treated, 14.19 +/- 1.73 muM; hemodialysis, 27.03 +/- 4.32 muM; CAPD, 22.38 +/- 3.73 muM; transplanted, 20.22 +/- 2.27 muM, p<0.001 vs. control]. Plasma protein damage was significantly higher in conservatively treated, hemodialysis (HD) and CAPD patients, while in transplant patients it was no different from the control. Conclusions: We concluded that in pediatric patients of different Italian geographical origin, plasma homocysteine levels were significantly higher in all groups with respect to healthy children; therefore contributing to the elevated cardiovascular risk present in these patients. Plasma protein L-isoaspartyl content was higher in renal failure patients, but kidney transplant patients had normal levels, indicating that this kind of protein damage relates more to the toxic action of uremic retention solutes, than to plasma homocysteine levels.
引用
收藏
页码:516 / 521
页数:6
相关论文
共 22 条
  • [1] DABBAGH S, 2001, J AM SOC NEPHROL, V12, pA4245
  • [2] De Laet C, 1999, AM J CLIN NUTR, V69, P968
  • [3] Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children - The Bogalusa Heart Study
    Greenlund, KJ
    Srinivasan, SR
    Xu, JH
    Dalferes, E
    Myers, L
    Pickoff, A
    Berenson, GS
    [J]. CIRCULATION, 1999, 99 (16) : 2144 - 2149
  • [4] KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431
  • [5] Hyperhomocysteinemia in stable pediatric, adolescents, and young adult renal transplant recipients
    Krmar, RT
    Ferraris, JR
    Ramirez, JA
    Galarza, CR
    Waisman, G
    Janson, JJ
    Llapur, CJ
    Sorroche, P
    Legal, S
    Cámera, MI
    [J]. TRANSPLANTATION, 2001, 71 (12) : 1748 - 1751
  • [6] Hyperhomocyst(e)inaemia in children with chronic renal failure
    Lilien, M
    Duran, M
    Van Hoeck, K
    Poll-The, BT
    Schröder, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (02) : 366 - 368
  • [7] MACFARLANE DE, 1984, J BIOL CHEM, V259, P1357
  • [8] EXPRESSION AND PURIFICATION OF A HUMAN RECOMBINANT METHYLTRANSFERASE THAT REPAIRS DAMAGED PROTEINS
    MACLAREN, DC
    CLARKE, S
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 1995, 6 (01) : 99 - 108
  • [9] HYPERHOMOCYSTEINAEMIA - A SIGNIFICANT RISK FACTOR FOR CARDIOVASCULAR-DISEASE IN RENAL-TRANSPLANT RECIPIENTS
    MASSY, ZA
    CHADEFAUXVEKEMANS, B
    CHEVALIER, A
    BADER, CA
    DRUEKE, TB
    LEGENDRE, C
    LACOUR, B
    KAMOUN, P
    KREIS, H
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) : 1103 - 1108
  • [10] Plasma homocysteine concentration in children with chronic renal failure
    Merouani, A
    Lambert, M
    Delvin, EE
    Genest, J
    Robitaille, P
    Rozen, R
    [J]. PEDIATRIC NEPHROLOGY, 2001, 16 (10) : 805 - 811